Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

被引:6
|
作者
Bikou, Olympia [1 ]
Hajjar, Roger J. [2 ]
Hadri, Lahouaria [1 ]
Sassi, Yassine [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA
[2] Phospholamban Fdn, New York, NY USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2020年 / 160期
基金
美国国家卫生研究院;
关键词
Medicine; Issue; 160; Hypoxia; SU5416; Sugen; pulmonary hypertension; PH; right ventricular pressure; pulmonary vascular remodeling; right ventricular remodeling; 5416/HYPOXIA MOUSE MODEL; ARTERIAL-HYPERTENSION; ANIMAL-MODELS;
D O I
10.3791/59252
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pulmonary Hypertension (PH) is a pathophysiological condition, defined by a mean pulmonary arterial pressure exceeding 25 mm Hg at rest, as assessed by right heart catheterization. A broad spectrum of diseases can lead to PH, differing in their etiology, histopathology, clinical presentation, prognosis, and response to treatment. Despite significant progress in the last years, PH remains an uncured disease. Understanding the underlying mechanisms can pave the way for the development of new therapies. Animal models are important research tools to achieve this goal. Currently, there are several models available for recapitulating PH. This protocol describes a two-hit mouse PH model. The stimuli for PH development are hypoxia and the injection of SU5416, a vascular endothelial growth factor (VEGF) receptor antagonist. Three weeks after initiation of Hypoxia/SU5416, animals develop pulmonary vascular remodeling imitating the histopathological changes observed in human PH (predominantly Group 1). Vascular remodeling in the pulmonary circulation results in the remodeling of the right ventricle (RV). The procedures for measuring RV pressures (using the open chest method), the morphometrical analyses of the RV (by dissecting and weighing both cardiac ventricles) and the histological assessments of the remodeling (both pulmonary by assessing vascular remodeling and cardiac by assessing RV cardiomyocyte hypertrophy and fibrosis) are described in detail. The advantages of this protocol are the possibility of the application both in wild type and in genetically modified mice, the relatively easy and low-cost implementation, and the quick development of the disease of interest (3 weeks). Limitations of this method are that mice do not develop a severe phenotype and PH is reversible upon return to normoxia. Prevention, as well as therapy studies, can easily be implemented in this model, without the necessity of advanced skills (as opposed to surgical rodent models).
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [21] Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats
    Luo, Fangmei
    Fu, Minyi
    Wang, Ting
    Qi, Yanan
    Zhong, Xuefeng
    Li, Dai
    Liu, Bin
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 747
  • [22] The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up
    Vitali, Sally H.
    Hansmann, Georg
    Rose, Chase
    Fernandez-Gonzalez, Angeles
    Scheid, Annette
    Mitsialis, S. Alex
    Kourembanas, Stella
    PULMONARY CIRCULATION, 2014, 4 (04) : 619 - 629
  • [23] Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats
    Zungu-Edmondson, Makhosazane
    Shults, Nataliia V.
    Melnyk, Oleksiy
    Suzuki, Yuichiro J.
    PLOS ONE, 2017, 12 (08):
  • [24] Treatment with Anti-Gremlin 1 Antibody Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension in Mice
    Ciuclan, Loredana
    Sheppard, KellyAnn
    Dong, Liqun
    Sutton, Daniel
    Duggan, Nicholas
    Hussey, Martin
    Simmons, Jenny
    Morrell, Nicholas W.
    Jarai, Gabor
    Edwards, Matthew
    DuBois, Gerald
    Thomas, Matthew
    Van Heeke, Gino
    England, Karen
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 183 (05) : 1461 - 1473
  • [25] Riociguat can ameliorate bronchopulmonary dysplasia in the SU5416 induced rat experimental model
    Katsuragi, Shinichi
    Ishida, Hidekazu
    Suginobe, Hidehiro
    Tsuru, Hirofumi
    Wang, Renjie
    Yoshihara, Chika
    Ueyama, Atsuko
    Narita, Jun
    Ishii, Ryo
    Kogaki, Shigetoyo
    Ozono, Keiichi
    EXPERIMENTAL LUNG RESEARCH, 2021, 47 (08) : 382 - 389
  • [26] Invasive Hemodynamic Assessment for the Right Ventricular System and Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
    Luo, Fuliang
    Wang, Xin
    Luo, Xiaokang
    Li, Bo
    Zhu, Desheng
    Sun, Hansong
    Tang, Yue
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (152):
  • [27] Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition
    Yu, Min
    Peng, Liyao
    Liu, Ping
    Yang, Mingxia
    Zhou, Hong
    Ding, Yirui
    Wang, Jingjing
    Huang, Wen
    Tan, Qi
    Wang, Yanli
    Xie, Weiping
    Kong, Hui
    Wang, Hong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1191 - 1202
  • [28] Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model
    Kuang, Meidan
    Chen, Yilin
    Xing, Yue
    Du, Min
    Feng, Huazhuo
    Yang, Qifeng
    Wen, Dongmei
    Li, Xuanyi
    Yang, Kai
    Lin, Ziying
    Lai, Ning
    Jiang, Qian
    Liu, Shiyun
    Zhou, Dansha
    Hong, Wei
    Fu, Xin
    Lu, Wenju
    Zhao, Tengteng
    Wang, Jian
    Chen, Yuqin
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [29] Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model
    Meidan Kuang
    Yilin Chen
    Yue Xing
    Min Du
    Huazhuo Feng
    Qifeng Yang
    Dongmei Wen
    Xuanyi Li
    Kai Yang
    Ziying Lin
    Ning Lai
    Qian Jiang
    Shiyun Liu
    Dansha Zhou
    Wei Hong
    Xin Fu
    Wenju Lu
    Tengteng Zhao
    Jian Wang
    Yuqin Chen
    Respiratory Research, 24
  • [30] Absence of the MFG-E8 gene prevents hypoxia-induced pulmonary hypertension in mice
    Wang, Jun
    Wu, Jixing
    Zhu, Xianying
    Chen, Jinkun
    Zhao, Jianping
    Xu, Yongjian
    Xie, Jungang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (01) : 587 - 600